Don Milligan

2.1k total citations
26 papers, 1.1k citations indexed

About

Don Milligan is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Don Milligan has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Genetics and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Don Milligan's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (6 papers). Don Milligan is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (6 papers). Don Milligan collaborates with scholars based in United Kingdom, United States and Denmark. Don Milligan's co-authors include David C. Linch, Stephen Mackinnon, Anne Parker, Robert K. Hills, Claire Dearden, Nigel H. Russell, Alan K. Burnett, Kirsty Thomson, Karl S. Peggs and Emma Morris and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Don Milligan

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Don Milligan United Kingdom	13	637	384	369	327	312	26	1.1k
Vincenzo Pavone Italy	16	389 0.6×	263 0.7×	617 1.7×	460 1.4×	118 0.4×	61	1.1k
Bernadette Corront France	15	464 0.7×	258 0.7×	327 0.9×	266 0.8×	117 0.4×	28	797
P Coser Italy	15	490 0.8×	215 0.6×	324 0.9×	339 1.0×	154 0.5×	38	914
K.F. Wong China	15	282 0.4×	184 0.5×	433 1.2×	359 1.1×	311 1.0×	56	875
Carmen Pedro Spain	15	392 0.6×	314 0.8×	413 1.1×	301 0.9×	126 0.4×	27	885
J P Jouet France	16	784 1.2×	292 0.8×	137 0.4×	172 0.5×	117 0.4×	26	991
K Blake United States	7	307 0.5×	267 0.7×	501 1.4×	371 1.1×	192 0.6×	10	853
SH Nantel Canada	13	473 0.7×	268 0.7×	366 1.0×	283 0.9×	128 0.4×	20	847
Alfonso Maria D’Arco Italy	13	269 0.4×	248 0.6×	358 1.0×	264 0.8×	107 0.3×	27	819
Ann E. Hunter United Kingdom	12	964 1.5×	272 0.7×	269 0.7×	459 1.4×	142 0.5×	20	1.3k

Countries citing papers authored by Don Milligan

Since Specialization

Citations

This map shows the geographic impact of Don Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Milligan more than expected).

Fields of papers citing papers by Don Milligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Milligan. The network helps show where Don Milligan may publish in the future.

Co-authorship network of co-authors of Don Milligan

This figure shows the co-authorship network connecting the top 25 collaborators of Don Milligan. A scholar is included among the top collaborators of Don Milligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don Milligan. Don Milligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Richard A., Amy A. Kirkwood, Pip Patrick, et al.. (2018). Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial. The Lancet Oncology. 19(10). 1328–1337. 52 indexed citations

Dennis, Mike, Nigel H. Russell, Robert K. Hills, et al.. (2015). Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia. Blood. 125(19). 2923–2932. 39 indexed citations

Burnett, Alan K., Nigel H. Russell, Robert K. Hills, et al.. (2015). A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients. Blood. 125(25). 3878–3885. 194 indexed citations

Lokare, Anand, Emmanouil Nikolousis, Neil Phillips, et al.. (2014). Reduced Intensity Allogeneic Stem Cell Transplant for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Hematology Reports. 6(1). 5119–5119. 4 indexed citations

Burnett, Alan K., Robert K. Hills, David Grimwade, et al.. (2012). Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial. Leukemia. 27(4). 843–851. 53 indexed citations

Oscier, David, Claire Dearden, Efrem Eren, et al.. (2012). Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. British Journal of Haematology. 159(5). 541–564. 114 indexed citations

Hillmen, Peter, D. Cohen, Kim Cocks, et al.. (2011). A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. British Journal of Haematology. 152(5). 570–578. 32 indexed citations

Michallet, Mauricette, Mohamed Sobh, Don Milligan, et al.. (2010). HUMAN LEUKOCYTE ANTIGEN MATCHING AND CONDITIONING IMPACT ON LONG-TERM TRANSPLANT OUTCOME AFTER ALLOGENEIC HSCT FOR CHRONIC LYMPHOCYTIC LEUKEMIA. Haematologica. 95. 223–223. 1 indexed citations

Thomson, Kirsty, Emma Morris, Don Milligan, et al.. (2010). T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma. Journal of Clinical Oncology. 28(23). 3695–3700. 103 indexed citations

10.

Schetelig, Johannes, Don Milligan, D Niederwieser, et al.. (2009). In vivo T-cell depletion in allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: a retrospective EBMT analysis. Bone Marrow Transplantation. 43. 2 indexed citations

11.

Dearden, Claire, Rachel Wade, Monica Else, et al.. (2007). The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood. 111(4). 1820–1826. 92 indexed citations

12.

Burnett, Alan K., Robert K. Hills, David Grimwade, et al.. (2007). Idarubicin and ATRA Is as Effective as MRC Chemotherapy in Patients with Acute Promyelocytic Leukaemia with Lower Toxicity and Resource Usage: Preliminary Results of the MRC AML15 Trial.. Blood. 110(11). 589–589. 14 indexed citations

13.

Hillmen, Peter, Christopher Pocock, D. Cohen, et al.. (2007). NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL.. Blood. 110(11). 752–752. 8 indexed citations

14.

Dearden, Claire, Rachel Wade, Monica Else, et al.. (2007). The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial.. Blood. 110(11). 2044–2044. 1 indexed citations

15.

Green, Anthony R., Peter J. Campbell, Linda M. Scott, et al.. (2005). JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.. Blood. 106(11). 253–253. 6 indexed citations

16.

Burnett, Alan K., Robert K. Hills, A H Goldstone, et al.. (2003). Attempts to modulate chemoresistance in older patients with AML using PSC-833 - Results of the LRF AML14 trial. Blood. 102. 4 indexed citations

17.

Annemans, Lieven, K Moeremans, David Mutimer, et al.. (2002). Modeling Costs and Cost-Effectiveness of Different CMV Management Strategies in Liver Transplant Recipients as a Support for Current and Future Decision Making. Value in Health. 5(4). 347–358. 8 indexed citations

18.

Milligan, Don, Andrea Tramarin, Andrew J. Ullmann, et al.. (2001). Abstracts of the 2001 Annual IDSA Meeting. Clinical Infectious Diseases. 33(7). 1087–1087. 2 indexed citations

19.

Salooja, Nina, R Chatterjee, Andrew McMillan, et al.. (1994). Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol.. PubMed. 13(4). 431–5. 35 indexed citations

20.

Goldstone, A. H., Andrew McMillan, R Powles, et al.. (1991). Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience.. Journal of Clinical Oncology. 9(10). 1840–1847. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact